Moving Off the Couch Brings Healthy Aging: Study Finds Benefit

It's tempting to binge-watch TV, but yet another study finds that when it comes to healthy aging, the less time on your sofa, the better.

The study looked at 20 years of data on more than 45,000 people taking part in the Nurses' Health Study. All were at least age 50 in 1992 and free of chronic disease when they entered the study.

Re...

Expert Panel Develops New Definition of Long COVID

A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says.

Long COVID is a chronic condition that occurs after COVID-19 infection and is present for at least three months, the new definition holds.

Federal officials asked th...

Space Travel Can Upset Human Immune Systems

Astronauts orbiting the Earth tend to suffer from immune system problems such as infections and the reactivation of dormant viruses, even on short-term space flights.

That appears to be because a lack of gravity causes the immune system to go awry during space travel, a new study has found.

Immune cells appear to grow differently in ...

Study Casts Doubt on Standard Test for Athletes' Concussion

A test used to gauge whether a college athlete has suffered a concussion is right only half the time and may be useless, new research finds.

The test used by the NCAA, which oversees college sports, measures an athlete's cognitive skills, and is one of three tests (symptoms and balance tests being the other two) that doctors use to identi...

Short Commercial Space Flights May Not Have Big Impact on Health

TUESDAY, June 11, 2024 (HealthDay News) — The first all-civilian space mission is shedding light on the potential health risks facing private astronauts.

The takeaway: Short-duration spaceflights appear to pose none that are significant.

The study sample was small — four people who spent three days in low-earth orbit (LEO) on the...

FDA Advisors Support New Alzheimer's Drug

A U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the benefits of a new drug for Alzheimer's outweigh its harms, which can include brain swelling and bleeding.

Eli Lilly's donanemab did slow declines in thinking skills in patients with early-stage Alzheimer's: Company data showed patients who ...